Procaps Group S.A. (NASDAQ:PROC) Sees Large Increase in Short Interest

Procaps Group S.A. (NASDAQ:PROC) saw a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 113,800 shares, a growth of 455.1% from the October 31st total of 20,500 shares. Based on an average trading volume of 68,700 shares, the days-to-cover ratio is presently 1.7 days. Currently, 0.6% of the shares of the stock are sold short.

Procaps Group Price Performance

NASDAQ:PROC traded up $0.73 during mid-day trading on Wednesday, hitting $2.09. 205,302 shares of the stock traded hands, compared to its average volume of 30,771. The business’s 50-day moving average price is $1.71 and its 200 day moving average price is $2.14. Procaps Group has a 12-month low of $0.50 and a 12-month high of $4.95.

Procaps Group Company Profile

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.